Responses
Clinical science
Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment
Compose a Response to This Article
Other responses
No responses have been published for this article.